Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT01339650 · COMPLETED

Trial details

NCT number: NCT01339650
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fallopian Tube Primary Peritoneal Cancer Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian

Start date: 2011-05-06
Primary completion: 2017-11-30
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.